Table 1. Clinicopathological characteristics of HCC patients in this study.
| Clinicopathological parameter | No. of patients (n = 82)(%) |
|---|---|
| Sex | |
| Male | 63/82 (76.8%) |
| Female | 19/82 (23.2%) |
| Age at diagnosis | |
| ≤65 | 41/82 (50.0%) |
| >65 | 41/82 (50.0%) |
| Tumour stage | |
| T1 | 13/82 (15.9%) |
| T2 | 24/82 (29.3%) |
| T3 | 33/82 (40.2%) |
| T4 | 8/82 (9.8%) |
| Missing | 4/82 (4.9%) |
| Tumour grade | |
| G1 | 22/82 (26.8%) |
| G2 | 49/82 (59.8%) |
| G3 | 10/82 (12.2%) |
| Missing | 1/82 (1.2%) |
| Growth pattern | |
| Trabecular | 37/82 (45.1%) |
| Trabecular-tubular | 24/82 (29.3%) |
| Trabecular-solide | 9/82 (11.0%) |
| Tubular | 2/82 (2.4%) |
| Fibro, trabecular-tubular-solide | 5/82 (6.1%) |
| Fibro-lamellar | 3/82 (3.7%) |
| Solide | 2/82 (2.4%) |
| Cirrhosis | |
| Yes | 52/80 (63.4%) |
| No | 28/80 (34.1%) |
| SOX9 expression | |
| Positive | 28/82 (34.1%) |
| Negative | 54/82 (65.9%) |